FeedPortfolioCopytradeTop TradersWhale Tracking
FeedPortfolioCopytradeTop TradersWhale Tracking

Will Theravance Biopharma (TBPH) beat quarterly earnings?

About this market

No 100% chance. Will Theravance Biopharma (TBPH) beat quarterly earnings? — live odds, $938 volume, resolves 2026-08-11. Trade on PredyX.

Current outcome probabilities for Will Theravance Biopharma (TBPH) beat quarterly earnings?
OutcomeProbability24h changeVolume
Yes0%0.0%—
No100%0.0%—

Rules

As of market creation, Theravance Biopharma is estimated to release earnings on August 11, 2026. The Street consensus estimate for Theravance Biopharma's GAAP EPS for the relevant quarter is $0.08 as of market creation. This market will resolve to "Yes" if Theravance Biopharma reports GAAP EPS greater than $0.08 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents. If Theravance Biopharma releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”. If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.

Category
other
Total volume
$938.29
Liquidity
$NaN
Resolution date
Aug 11, 2026
Condition ID
0x571dddd8c69f6962d30953cafa123f87aab34c7ec31e129bd7271ac49871a856

Frequently asked questions

What are the current odds for Will Theravance Biopharma (TBPH) beat quarterly earnings??
As of today, Yes at 0%, No at 100%, based on live Polymarket trading data.
When does "Will Theravance Biopharma (TBPH) beat quarterly earnings?" resolve?
This market resolves on August 11, 2026.
How much has been traded on Will Theravance Biopharma (TBPH) beat quarterly earnings??
Total trading volume is $938.
How do I trade "Will Theravance Biopharma (TBPH) beat quarterly earnings?"?
You can trade this Polymarket prediction market directly from your browser on PredyX — a non-custodial trading terminal with live odds, limit orders, and copy trading.
More other marketsWill Theravance Biopharma (TBPH) beat quarterly earnings?Will Theravance Biopharma (TBPH) beat quarterly earnings?Will Theravance Biopharma (TBPH) beat quarterly earnings?View on Polymarket

Last updated Nov 22, 2026